Sunrise Resources Plc (LON:SRES) revealed that soil sampling has revealed that copper sulphide mineralisation related to pegmatites and quartz veins is evident at surface in numerous showings along a strike length of nearly 1,600 metres at the Junction project in Nevada.
The vanadium joint venture of Bushveld Minerals Limited (LON:BMN), Vametco Alloys, has delivered strong third quarter results, helped by improved vanadium prices. Bushveld acquired its 45% interest in Vametco in April.
Haydale Graphene Industries PLC (LON:HAYD) has filed a new patent application in the UK for its PATit anti-counterfeiting technology, which uses proprietary software codes and a specialty graphene-based, transparent conductive ink.
Wishbone Gold PLC (LON:WSBN) and D-Beta One have modified the equity sharing agreement announced on 18 August 2017, doubling the number of monthly repayments from 10 to 20.
Savannah Resources Plc (LON:SAV) has completed construction of a pilot plant that will undertake bulk sampling at the Mutamba mineral sands project in Mozambique. The results from the tests will be used to underpin plans for larger scale production.
Specialist medical imaging group Feedback plc (LON:FDBK) has finally received a CE mark for its TexRAD Lung technology. The company had previously expected the CE mark by the end of May but this date was pushed back after it came up with several enhancements that have improved the performance of TexRAD Lung.
Hummingbird Resources PLC (LON:HUM) remains on track for first gold production at Yanfolila by the end of this year. Testing of the ball mill is now complete, the water supply is in place, and the commissioning of the carbon-in-leach circuit is now underway.
Silence Therapeutics PLC (LON:SLN) has served its defence in the legal actions initiated against it by Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) and The Medicines Company.
Jubilee Platinum PLC (LON:JLP) delivered revenue growth in October as platinum production at the Hernic mine continued to ramp up. Revenue from the South Africa project rose 18% to £760,000 compared to a month ago on the back of a 22% month-on-month gain in production to 1,427 ounces of platinum (PGM).
SDX Energy Plc (LON:SDX) has told investors that the ongoing development drilling programme in Morocco continues to deliver results ahead of the company’s own expectations. The North Africa focussed oil and gas firm, in a stock market statement, confirmed that the KSR-14 well has measured an average production rate of 6.4mln cubic feet of gas per day during testing, and will remain on production for an extended period.
Shanta Gold (LON:SHG) has boosted its identified gold in Tanzania to more than 2mln ounces with a first published resource at the Singida prospect. Singida, in the centre of the country, now has an Australian standard JORC resource of 728,000oz stemming from 12.3mt at a grade of 1.84 g/t. The cut-off grade was 1.0 g/t.
Chaarat Gold Holdings Limited (LON:CGH) has completed its 2017 exploration programme at Tulkubash with 60% more metres drilled than originally expected. As a result, the indicative length of the proposed open pit has doubled to 2,200 metres as the current Tulkubash pit now connects with other previously drilled satellite pits.
Sound Energy PLC (LON:SOU) told investors that a survey of its acreage in Eastern Morocco has now been completed. The explorer conduction both airborne full tensor gravity gradiometry (FTG) and magnetic data acquisition programmes, with contractor AustinBridgeporth flying some 26,700 kilometres to cover a 22,800 Square kilometre area including the Tendrara field and the Matarka and Anoual exploration areas.
BOS GLOBAL Holdings’s (LON:BOS) directors have agreed to stand down, but only if former chief executive Michael Travia also ends his attempt to be reinstated.
Eurasia Mining plc (LON:EUA) said Venus Garden Holdings Limited (VGH) is planning a direct equity investment in the West Kytlim gold and platinum mine in Russia.
VGH - owned by Alexei Churakov, who has held positions at Goldman Sachs and Morgan Stanley – has subscribed £76,336 for 27,262,814 new ordinary shares of 0.1p each in the share capital of the AIM-listed precious metal explorer at a price of 0.28p.
Summit Therapeutics PLC (LON:SUMM) (NASDAQ:SMMT) has completed the initial 24-weeks of dosing of ezutromid in patients with Duchenne muscular dystrophy (DMD) in a phase 2 clinical trial.
The drug discovery and development company expects to report results from the initial dosing period in the first quarter of 2018, putting it on track to conduct the planned biopsy, MRI and functional analyses.